Literature DB >> 23911355

Contrasting patterns of tolerance between chemical and biological insecticides in mosquitoes exposed to UV-A.

Guillaume Tetreau1, Alexia Chandor-Proust, Frédéric Faucon, Renaud Stalinski, Idir Akhouayri, Sophie M Prud'homme, Muriel Raveton, Stéphane Reynaud.   

Abstract

Mosquitoes are vectors of major human diseases, such as malaria, dengue or yellow fever. Because no efficient treatments or vaccines are available for most of these diseases, control measures rely mainly on reducing mosquito populations by the use of insecticides. Numerous biotic and abiotic factors are known to modulate the efficacy of insecticides used in mosquito control. Mosquito breeding sites vary from opened to high vegetation covered areas leading to a large ultraviolet gradient exposure. This ecological feature may affect the general physiology of the insect, including the resistance status against insecticides. In the context of their contrasted breeding sites, we assessed the impact of low-energetic ultraviolet exposure on mosquito sensitivity to biological and chemical insecticides. We show that several mosquito detoxification enzyme activities (cytochrome P450, glutathione S-transferases, esterases) were increased upon low-energy UV-A exposure. Additionally, five specific genes encoding detoxification enzymes (CYP6BB2, CYP6Z7, CYP6Z8, GSTD4, and GSTE2) previously shown to be involved in resistance to chemical insecticides were found over-transcribed in UV-A exposed mosquitoes, revealed by RT-qPCR experiments. More importantly, toxicological bioassays revealed that UV-exposed mosquitoes were more tolerant to four main chemical insecticide classes (DDT, imidacloprid, permethrin, temephos), whereas the bioinsecticide Bacillus thuringiensis subsp. israelensis (Bti) appeared more toxic. The present article provides the first experimental evidence of the capacity of low-energy UV-A to increase mosquito tolerance to major chemical insecticides. This is also the first time that a metabolic resistance to chemical insecticides is linked to a higher susceptibility to a bioinsecticide. These results support the use of Bti as an efficient alternative to chemical insecticides when a metabolic resistance to chemicals has been developed by mosquitoes.
Copyright © 2013 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Aedes aegypti; Bioassays; Candidate gene expression; Enzymatic activities; RT-qPCR; Ultraviolet

Mesh:

Substances:

Year:  2013        PMID: 23911355     DOI: 10.1016/j.aquatox.2013.07.004

Source DB:  PubMed          Journal:  Aquat Toxicol        ISSN: 0166-445X            Impact factor:   4.964


  4 in total

1.  Chemical and biological insecticides select distinct gene expression patterns in Aedes aegypti mosquito.

Authors:  Laurence Després; Renaud Stalinski; Frédéric Faucon; Vincent Navratil; Alain Viari; Margot Paris; Guillaume Tetreau; Rodolphe Poupardin; Muhammad Asam Riaz; Aurélie Bonin; Stéphane Reynaud; Jean-Philippe David
Journal:  Biol Lett       Date:  2014-12       Impact factor: 3.703

2.  High larvicidal efficacy of yeast-encapsulated orange oil against Aedes aegypti strains from Brazil.

Authors:  Mariana Rocha David; Fernando Ariel Genta; Bruno Gomes; Huarlen Ogélio; Fabiane Brant; Camila Jesus Pereira-Pinto; Michael J Workman; Monique Costa; José Bento Pereira Lima; Ademir Jesus Martins; Marcelo Ramalho-Ortigao; Ravi Durvasula; Ivy Hurwitz
Journal:  Parasit Vectors       Date:  2021-05-22       Impact factor: 3.876

3.  Alternative insecticides for larval control of the dengue vector Aedes aegypti in Lao PDR: insecticide resistance and semi-field trial study.

Authors:  Sébastien Marcombe; Somsanith Chonephetsarath; Phoutmany Thammavong; Paul T Brey
Journal:  Parasit Vectors       Date:  2018-12-03       Impact factor: 3.876

4.  Melanotic pathology and vertical transmission of the gut commensal Elizabethkingia meningoseptica in the major malaria vector Anopheles gambiae.

Authors:  Idir G Akhouayri; Tibebu Habtewold; Georges K Christophides
Journal:  PLoS One       Date:  2013-10-01       Impact factor: 3.240

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.